Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,030 | 251 | 94.8% |
| Travel and Lodging | $498.55 | 2 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intersect ENT, Inc. | $2,960 | 23 | $0 (2021) |
| Acclarent, Inc | $1,965 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $925.95 | 59 | $0 (2024) |
| Optinose US, Inc. | $564.01 | 21 | $0 (2024) |
| GENZYME CORPORATION | $501.76 | 19 | $0 (2024) |
| kaleo, Inc. | $305.09 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $233.43 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $231.91 | 7 | $0 (2024) |
| Entellus Medical, Inc. | $227.65 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $196.87 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $791.94 | 33 | GlaxoSmithKline, LLC. ($184.58) |
| 2023 | $806.06 | 32 | kaleo, Inc. ($192.14) |
| 2022 | $822.27 | 31 | Acclarent, Inc ($263.90) |
| 2021 | $1,622 | 43 | Acclarent, Inc ($502.18) |
| 2020 | $887.58 | 20 | Acclarent, Inc ($431.93) |
| 2019 | $2,026 | 47 | Intersect ENT, Inc. ($837.85) |
| 2018 | $496.03 | 23 | Intersect ENT, Inc. ($96.84) |
| 2017 | $2,076 | 24 | Intersect ENT, Inc. ($1,515) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $36.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: Immunology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/16/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/13/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Allergy | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $50.50 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/20/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Immunology | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/12/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Allergy | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,174 | 1,470 | $487,272 | $142,257 |
| 2022 | 8 | 830 | 967 | $313,381 | $92,849 |
| 2021 | 9 | 809 | 1,010 | $297,398 | $100,938 |
| 2020 | 8 | 695 | 842 | $207,292 | $78,321 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 206 | 290 | $222,140 | $49,641 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 421 | $91,357 | $33,200 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 144 | 144 | $28,800 | $14,157 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 117 | $26,325 | $13,761 | 52.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 82 | 91 | $26,390 | $10,817 | 41.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 157 | 202 | $55,870 | $7,531 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $18,000 | $6,728 | 37.4% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 90 | 90 | $9,810 | $3,945 | 40.2% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2023 | 15 | 18 | $5,760 | $1,974 | 34.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 17 | 47 | $2,820 | $504.24 | 17.9% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 142 | 177 | $135,582 | $31,113 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 306 | $66,402 | $23,537 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 112 | 112 | $22,400 | $11,109 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 66 | $14,850 | $7,704 | 51.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 47 | 49 | $14,210 | $5,998 | 42.2% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 122 | 147 | $40,166 | $5,433 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $11,160 | $4,596 | 41.2% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 79 | 79 | $8,611 | $3,359 | 39.0% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 144 | 205 | $134,794 | $39,118 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 233 | 326 | $61,497 | $25,241 | 41.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 152 | 152 | $30,400 | $14,680 | 48.3% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 110 | 144 | $34,471 | $5,676 | 16.5% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 38 | 45 | $13,050 | $5,450 | 41.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 44 | $9,900 | $5,097 | 51.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2021 | 64 | 66 | $7,194 | $2,795 | 38.9% |
About Dr. Eric Cohen, M.D
Dr. Eric Cohen, M.D is a Plastic Surgery within the Head & Neck healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508950163.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Cohen, M.D has received a total of $9,528 in payments from pharmaceutical and medical device companies, with $791.94 received in 2024. These payments were reported across 253 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,030).
As a Medicare-enrolled provider, Cohen has provided services to 3,508 Medicare beneficiaries, totaling 4,289 services with total Medicare billing of $414,366. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Plastic Surgery within the Head & Neck
- Location New York, NY
- Active Since 10/03/2006
- Last Updated 01/24/2019
- Taxonomy Code 207YX0007X
- Entity Type Individual
- NPI Number 1508950163
Products in Payments
- PROPEL (Device) $2,742
- TruDi NAV Cable (Device) $890.27
- NUCALA (Biological) $669.02
- DUPIXENT (Biological) $632.41
- Xhance (Drug) $564.01
- TruDi Navigation System (Device) $380.26
- AUVI-Q (Drug) $305.09
- TruDi (Device) $276.42
- TRELEGY ELLIPTA (Drug) $256.93
- XprESS Multi-Sinus Dilation System (Device) $227.65
- SINUVA (Drug) $218.24
- C Topical Solution 4 CII (Drug) $155.92
- FASENRA (Biological) $140.01
- XOLAIR (Drug) $129.45
- DUPIXENT (Drug) $124.21
- ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE (Device) $110.30
- AirDuo Digihaler (Drug) $102.31
- ACCLARENT SE Inflation Device (Device) $96.05
- Ryaltris (Drug) $95.66
- Odactra (Drug) $94.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Plastic Surgery within the Head & Neck Doctors in New York
Tal Dagan, Md Facs, MD FACS
Plastic Surgery within the Head & Neck — Payments: $4,346
Dr. George Braun, M.d, M.D
Plastic Surgery within the Head & Neck — Payments: $4,182
Dr. Abraham Zimm, M.d, M.D
Plastic Surgery within the Head & Neck — Payments: $1,845
Guy Lin, M.d, M.D
Plastic Surgery within the Head & Neck — Payments: $1,661
Michael Jones
Plastic Surgery within the Head & Neck — Payments: $927.08
Moustafa Mourad, M.d, M.D
Plastic Surgery within the Head & Neck — Payments: $838.51